Proactive - Interviews for investors

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce the launch of their AI-Powered 3D model search engine. This groundbreaking AI search engine incorporates computer vision and artificial intelligence to streamline and accelerate the 3D modeling process.

Gappelberg explained that the AI-based search engine uses images to search Nextech's internal library of 3D models, providing recommendations for models that closely match the given image. This innovative technology significantly expedites the 3D model creation process, enabling Nextech to produce a greater number of 3D models efficiently. Within seconds, 3D artists can choose from multiple 3D matches, capitalizing on the company's library of pre-existing 3D models with similar colors, textures, and shapes.

The development of this AI 3D model search engine was an in-house achievement, showcasing Nextech's technical prowess and the expertise of their team of AI engineers and scientists. This innovation promises to enhance and streamline their 3D modeling operations, providing Nextech3D.ai with a competitive edge in the market.

#proactiveinvestors #nextech3d.ai #cse #NTAR #otcqb #metaverse #toggle3D

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Metals Energy Corp CEO James Sykes joined Steve Darling from Proactive to provide details about the company's upcoming inaugural drill program at the SourceRock lithium brine project near Thunder Bay, Ontario, set to commence in early January.

Sykes explained that SourceRock is a drill-ready project equipped with an exploration permit for up to 20 drill pads. Historical drilling and geophysical data have already identified saline brine drill targets within the project. However, these brines have never been tested for lithium or other essential elements. SourceRock is situated within an ancient sedimentary basin, possessing all the necessary criteria for potentially discovering Ontario's first lithium brines.

With government support and recognizing the project's importance, Sykes anticipates swift progress, with the drill crew expected on-site within a week. The interview concludes with a sense of excitement and anticipation, highlighting the potential positive outcomes for Metal Energy Corp and the broader lithium market. Stay tuned for updates as the company works to validate its ambitious lithium brine project in Ontario.

#proactiveinvestors #metalenergycorp #tsxv #merg #mining #nickel

#LithiumProject, #OntarioMining, #ResourceExploration, #GreenEnergy, #CleanTech, #MiningInnovation, #LithiumBrineDiscovery, #SustainableMining, #MineralExploration, #RenewableResources, #EnergyRevolution, #GlobalImpact, #MiningTechnology, #GreenEconomy, #FutureOfEnergy, #MineralResources, #LithiumDemand, #InnovationInMining, #OntarioBusiness, #EnvironmentalImpact, #EnergySustainability, #MiningUpdates, #InvestmentOpportunity#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive and founder Andrew Newland visits the Proactive London studio to speak with Thomas Warner after the liquid biopsy company announced what it calls "groundbreaking" clinical results from its latest research.

ANGLE's research focused on addressing cancer's progression and the challenges of evolving treatments. Newland explains that traditional oncology relies on tissue biopsy for targeted therapy, but this method becomes ineffective as cancer changes. ANGLE's solution involves analysing both circulating tumour DNA (from dead cancer cells) and living cancer cells in blood, using their Parsortix system.

This novel approach allows for repeated non-invasive biopsies, providing critical information on cancer evolution and treatment efficacy. Their study involved 47 patients with four cancer types (breast, lung, ovarian, prostate) and identified actionable cancer mutations in living cells, not found in dead cells. These findings could lead to more effective, personalised treatments, as many of these variants are targetable with existing FDA-approved drugs.

ANGLE's next steps involve commercialising this technology by offering services to pharmaceutical companies and publishing protocols for wider adoption. Their focus is on improving cancer patient outcomes through this innovative blood test method.

Additionally, ANGLE announced a significant contract with Eisai Inc., a large Japanese pharmaceutical company, to pilot their HER2 assay in clinical trials. This contract marks a major step in ANGLE's business growth and their commitment to advancing cancer treatment and diagnostics.

#ANGLEPLC #CancerResearch #OncologyInnovation #AndrewNewland #CancerDiagnostics #TargetedTherapy #CancerTreatment #BloodTestCancer #PersonalizedMedicine #OncologyNews #HealthcareTechnology #MedicalResearch #BreastCancer #LungCancer #OvarianCancer #ProstateCancer #CTDNAAnalysis #LivingCancerCells #FDAApprovedDrugs #PharmaceuticalPartnerships #Epsych #CancerTherapies #HealthTech #MedicalBreakthroughs #CancerProgression #ClinicalTrials #CancerCare #BioTech #OncologyInterview #HealthcareAdvancements #CancerAwareness #ProactiveInvestors #InsertCompanyName #InsertStockMarket #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

In a dramatic turn of events, Bitcoin's value plummeted over 4.5% following speculation that the U.S. Securities and Exchange Commission (SEC) might reject several high-profile Bitcoin-based Exchange-Traded Funds (ETFs) applications.

This significant drop in Bitcoin's price highlights the cryptocurrency's notorious volatility and market sensitivity to regulatory news. Major players in the crypto space, including BlackRock, VanEck, and Grayscale, are at the forefront of this uncertainty, as detailed in a critical article by Matrixport.

The broader cryptocurrency market echoed Bitcoin's decline, with Ethereum experiencing its worst session in five months and other altcoins like Solana, Cardano, and Dogecoin also facing steep losses.

This recent market shakeup underscores the growing pains of cryptocurrencies as they strive for mainstream acceptance and stability in the global financial landscape.

#ProactiveInvestors #Bitcoin #Cryptocurrency #ETF #SEC #MarketVolatility #CryptoNews #Matrixport #BitcoinETF #CryptocurrencyMarket #BitcoinCrash #Blockchain #DigitalCurrency #FinanceNews #CryptoTrading #Ethereum #Altcoins #Investment #FinancialRegulation #CryptoAnalysis #MarketUpdate #TechNews #FinancialTrends #BitcoinDominance #CryptoInvestment #FinancialMarkets #CryptoUpdate #BlockchainTechnology #CryptoEconomy #GlobalFinance #MarketInsights #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

GoviEx Uranium Inc (TSX-V:GXU, OTCQX:GVXXF) CEO Daniel Major speaks to Thomas Warner from Proactive after the Africa-focused mineral resource company announced that it has completed an extensive drill program in support of its ongoing feasibility study at its 100%-owned Muntanga uranium project located in Zambia.

Major puts the drill campaign in context and says he anticipates the upcoming feasibility study will reflect enhanced volume and tonnage, although final results are pending geologist analysis.

Additionally, GoviEx is focusing on sustainable practices, with plans to use green power from Lake Kariba as well as efforts to reduce water and power consumption. The CEO expresses confidence in maintaining capital costs at 2017 levels despite potential technical risks. Major remains cautiously optimistic about the uranium market, with prices currently favorable for the company.

The feasibility report, expected in summer 2024, will be a significant milestone for GoviEx, post which they plan to move into project financing.

#GoviExUranium #DanielMajor #UraniumMining #MiningIndustry #ResourceEstimation #InfillDrilling #SustainableMining #UraniumMarket #MineralResources #FeasibilityStudy #GreenEnergy #MiningTechnology #UraniumInvestment #ResourceDevelopment #EnergySector #UraniumPrices #ProactivInterview #MiningFinance #MadaouelaProject #NigerMining

#ProactiveInvestors #uranium #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

C4X Discovery Holdings PLC (AIM:C4XD) Chief Business Officer Bhavna Hunjan and Chief Scientific Officer Nick Ray speak to Thomas Warner from Proactive after the drug discovery company announced receipt of a US$11 million payment under its US$402 million deal with pharma giant AstraZeneca PLC (LSE:AZN).

Specifically, the financial landmark marks the progression of the NRF2 Activator programme, created by C4XD and outlicensed to AZ.

Nick Ray elaborates on NRF2, a molecule critical in regulating cellular oxidative stress and inflammatory responses, saying that the discovery has potential applications in various inflammatory diseases like COPD, sickle cell disease, and multiple sclerosis. He adds that C4X's focus on immuno-inflammatory diseases aligns with AstraZeneca's interest in chronic respiratory diseases.

Moreover, C4X's license with Sanofi for an IL-17 inhibitor program further diversifies its portfolio, with an anticipated $800 million in potential milestones plus royalties.

Hunjan also explains more about how C4X Discovery is positioned heading into the new year, suggesting that the business has shown itself able to navigate the challenging economic environment and capitalise on opportunities in immuno-inflammatory therapies.

#C4XDiscovery #PharmaceuticalIndustry #NRF2 #InflammatoryDiseases #AstraZenecaPartnership #HealthcareInnovation #Biotechnology #ChronicDiseases #MedicalResearch #DrugDevelopment #SanofiCollaboration #ScientificAdvancements #BiopharmaNews #HealthTech #ClinicalTrials #RespiratoryDiseases #InflammatoryBowelDisease #Biopharmaceuticals #MedicalBreakthroughs #HealthcareTrends

#ProactiveInvestors #InsertCompanyName #InsertStockMarket

LEAVE THESE IN AS STANDARD & ADD ANY YOU FEEL ARE RELEVENT

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Good morning from London, where the FTSE 100 is up once again at right around 7,700 points – the big gainer so far is Leicester-based fashion chain Next up a whopping 5% after increasing its profit guidance for the year. Sales during November and December were better than anticipated and they’re now expecting full year pre-tax profits of £905 million, up 4% on the year.

A point of interest there is that sales accelerated as Christmas approached, but the same can’t be said over at fellow high street operator JD Sports. They’ve lowered their guidance after a softer and more promotional festive period than they were expecting.

And Topps Tiles are also walking wounded into the new year, blaming a Q4 drop in sales of 4% on what they call “ongoing challenges in discretionary spending.” Zooming out now with a look at the macro picture and Goldman Sachs is predicting that the Bank will start cutting interest rates in May, and drop them by 25 basis points all the way down to an eventual 3% in May 2025.

And finally Stuart O’Reilly from the Royal Mint says that gold prices may not yet have peaked, suggesting that events in 2024 could “turbocharge gold beyond recent market highs.”

Lots to look forward to this year and indeed today, I’ll be talking uranium a little later as well as speaking with several chief executives from the UK’s fascinating biotech sector so make sure you check back later – all the best til then.

#ProactiveInvestors #FTSE100 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

RocketFuel Inc. Vice President Daniel Gonzalvez takes Proactive's Stephen Gunnion through the strong growth the company experienced in 2023 as it achieved its sixth consecutive quarter of over 100% revenue growth.

The company enhanced its payment product, boosting conversion rates, and expanded its cross-border payment solution. Two successful product launches included a payout system for businesses managing numerous recipients and a gift card solution to combat declines and chargebacks.

RocketFuel operates across diverse market segments, serving small businesses to enterprises. Notably, the company remains agnostic to currency types, facilitating payments in fiat or crypto globally.

Gonzalvez anticipates continued growth in 2024, emphasizing the significance of alternative payment methods amidst the evolving digital currency landscape. Despite market fluctuations, RocketFuel remains positioned to address payment processing challenges.

The company is geared for the blockchain's increasing integration into daily life, aligning itself as a web 2.5 to web 3.0 company. A recent partnership with Ripple underscores RocketFuel's commitment to innovative money movement solutions.

As Gonzalvez looks forward to 2024, he hints at optimizing existing solutions and potential new product lines, hinting at loyalty programs. The company aims to sustain its growth trajectory while prioritizing efficiency, conversions, and revenue optimization.

#RocketFuel #DigitalPayments #FinTechGrowth #2023Success #PaymentSolutions #CryptoNews #BlockchainTech #FinancialInnovation #CrossBorderPayments #TechUpdates #RipplePartnership #CryptoTrends #PaymentRevolution #FinancialServices #2024Outlook #BusinessSolutions #TechIndustry #FinanceTech #GlobalTransactions #InnovationLeaders #CryptoAdoption #Web3 #FinancialTech #LoyaltyPrograms #YouTubeInterview #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Cloud DX Inc CEO Robert Kaul joined Proactive's Stephen Gunnion with news the company has kicked off 2024 with a significant deal with Health PEI, the provincial health authority for Prince Edward Island. This follows a successful competitive Request for Proposal (RFP) for remote patient monitoring with Mohawk MedBuy, the largest hospital procurement agency in Canada.

Cloud DX emerged as the sole vendor, streamlining the purchasing process for over 100 hospital systems and provincial governments.

The latest provincial contract spans home care, primary care, and rehabilitation care, addressing three key components of the healthcare system. This three-year contract, extendable to seven years, represents the second major deal under the Master Agreement, signaling stability and long-term prospects for Cloud DX. With remote patient monitoring gaining traction, the company anticipates continued growth in deals as more hospital systems embrace virtual care.

Cloud DX's proven Remote Patient Monitoring (RPM) system, with a decade of experience and multiple peer-reviewed studies, promises enhanced efficiency, cost savings, and improved health outcomes, aligning with the evolving demands of Canadians for accessible and high-quality healthcare services.

#CloudDX #HealthTech #RemoteMonitoring #VirtualCare #HealthcareInnovation #Telehealth #DigitalHealth #PatientCare #HealthIT #ProvincialContracts #MohawkMedBuy #HealthPEI #MedicalTechnology #RPM #HealthcareRevolution #TechInHealth #HealthcareSolutions #InnovativeHealth #CanadianHealthcare #MedicalAdvancements #2024Healthcare #HealthcareNews #DigitalTransformation #PatientOutcomes #HealthcareTechTrends

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

KwikClick Inc CEO Fred Cooper discusses the company's unique software platform in an interview with Proactive's Stephen Gunnion.

KwikClick serves as a comprehensive rewards program for brands, catering to those without existing programs or seeking customization. The platform offers modules for loyalty points, cashback, rewards, and lottery giveaways. It also monetizes word-of-mouth marketing through an affiliate program.

Cooper emphasized tailoring rewards programs to individual companies, ensuring they align with customer acquisition goals. Influencers play a crucial role, earning commissions for driving sales and generating new customers.

KwikClick's growth is notable, with one brand experiencing a 250% increase in sales within the first week of adopting the platform.

Recent enhancements, including Zapier integration and improved checkout, aim to simplify the rewards process.

Cooper hinted at a potential uplisting and expressed optimism for KwikClick's 2024 focus on client adoption and sales growth. The platform's ease of use and innovative approach position it as a promising player in the rewards program market.

#KwikClick #RewardsProgram #InfluencerMarketing #MarketingTech #BrandInnovation #DigitalMarketing #CustomerRetention #AffiliateProgram #SalesGrowth #TechInnovation #WordOfMouth #BusinessSolutions #SEO #QRcodes #Ecommerce #BrandManagement #2024Trends #TechUpdates #CustomerExperience #DigitalTransformation #SalesBoost #PlatformEnhancements #BusinessSuccess #LoyaltyProgram #CEOInsights

#ProactiveInvestors #InsertCompanyName #InsertStockMarket #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews